Your shopping cart is empty

Subscriber login

Advanced Search

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

Check out our free and informative ezines and sign up now

Home > Newsletters > Drug Industry Daily > FDA Warns Indiana Hospital IRB for Inadequate Pediatric Protections

Drug Industry Daily

Nov. 1, 2012 | Vol. 11 No. 215

FDA Warns Indiana Hospital IRB for Inadequate Pediatric Protections

The FDA has handed a warning letter to the Memorial Hospital of South Bend institutional review board (IRB) for failing to adequately protect child participants in clinical trials.

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
Email This Article
RSS
Free Trial
Archives
Sample PDF

House Committee Investigates FDA Official’s Sudden Departure FDA Rejects Endo Petition To Deny Opana Generics FDA to Focus on HIV in Next Patient-Focused Drug Development Meeting FDA Hydrocodone Decision Delay Reflects Enforcement, Access Tensions

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.